• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

Comprehensive Overview of 3-Isobutoxy-4-methoxyphenylboronic Acid (CAS No. 1217501-19-3): Properties, Applications, and Industry Insights

3-Isobutoxy-4-methoxyphenylboronic Acid (CAS No. 1217501-19-3) is a specialized boronic acid derivative widely recognized for its role in organic synthesis and pharmaceutical research. This compound belongs to the arylboronic acid family, characterized by its unique isobutoxy and methoxy functional groups, which enhance its reactivity in cross-coupling reactions. With the growing demand for high-precision intermediates in drug development, this chemical has gained significant attention for its versatility and efficiency in Suzuki-Miyaura coupling reactions.

In recent years, the pharmaceutical and agrochemical industries have increasingly focused on sustainable synthesis methods, aligning with global trends toward green chemistry. 3-Isobutoxy-4-methoxyphenylboronic Acid serves as a key building block in the production of biologically active molecules, including potential therapeutics for central nervous system (CNS) disorders and anti-inflammatory agents. Researchers are particularly interested in its low toxicity profile and compatibility with catalytic systems, making it a preferred choice for scalable manufacturing.

The compound’s structural stability under mild reaction conditions has also spurred innovations in material science. For instance, it is explored in the design of organic electronic materials and liquid crystal displays (LCDs), where its electron-donating properties improve device performance. As industries prioritize energy-efficient technologies, the demand for such advanced intermediates is projected to rise.

From a market perspective, 1217501-19-3 is often searched alongside terms like "boronic acid catalysts", "Suzuki coupling reagents", and "pharmaceutical intermediates suppliers". These long-tail keywords reflect user intent, ranging from academic research to industrial procurement. Analytical platforms highlight its association with peptide modification and proteomics research, further expanding its applications in bioconjugation.

Quality control is critical for 3-Isobutoxy-4-methoxyphenylboronic Acid, with HPLC and NMR being standard techniques to verify purity (>98%) and structural integrity. Suppliers often emphasize batch-to-batch consistency to meet regulatory standards, particularly for GMP-compliant production. Storage recommendations typically include anhydrous conditions and low-temperature environments to prevent degradation.

Emerging studies also investigate its potential in cancer research, where boronic acids are leveraged for targeted drug delivery systems. While 1217501-19-3 is not directly classified as a therapeutic, its derivatives contribute to kinase inhibitor development—a hot topic in precision medicine forums. This aligns with the broader industry shift toward personalized healthcare solutions.

In summary, 3-Isobutoxy-4-methoxyphenylboronic Acid (CAS No. 1217501-19-3) exemplifies the intersection of chemical innovation and industrial applicability. Its relevance spans drug discovery, material engineering, and catalysis, driven by evolving scientific and commercial needs. As research continues to uncover new functionalities, this compound is poised to remain a staple in high-value chemical synthesis.

• 150145-31-6(4-Methoxy-3-propoxyphenylboronic Acid)
• 153624-44-3(4-Isobutoxyphenylboronic acid)
• 149557-18-6(3-propoxyphenylboronicacid)
• 849052-21-7(3-Isobutoxyphenylboronic acid)
• 1236191-14-2(3-(Neopentyloxy)phenylboronic Acid)
• 938443-38-0(4-(Neopentyloxy)phenylboronic acid)
• 1217501-14-8(3-Butoxy-4-methoxyphenylboronic acid)
• 915201-13-7(3-Ethoxy-4-methoxyphenylboronic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)